Category: Treatment for COVID-19
-
Dr. Peter McCullough: Successful early treatment for COVID makes vaccines unnecessary
The following is a 19-minute video featuring Dr. Peter McCullough’s Senate testimony about the veracity of early treatment protocols. Here are some of the more important points raised by Dr. McCullough in his testimony: COVID has always been a treatable disease. Early treatment could have saved 85% or 425,000 American lives. There is no one…
-
New study: WHO data shows Remdesevir causes serious bradycardia among COVID-19 patients
This study was published by the journal of Clinical Microbiology and Infection last May 1, 2021. Using reports from the World Health Organization (WHO)’s VigiBase, the researchers assessed the increased risk of bradycardia among COVID-19 patients who were exposed to remdesevir. The analysis included all reports of COVID-19 patients registered until September 23, 2020. The…
-
India Bar Association issue cease and desist notice to WHO chief scientist
The following document is a copy of the notice issued by the Indian Bar Association (IBA) to Dr. Soumya Swaminathan, Chief Scientist for India of the World Health Organization (WHO). The notice was made public on May 26, 2021. According to the notice, Dr. Swaminathan has ignored the extensive studies carried out by the Front…
-
How Ivermectin’s success has been suppressed by mainstream media
This May 26, 2021 article published by Zero Hedge features the 15-page article written by New York Times best-selling author, Michael Capuzzo. the article entitled The Drug That Cracked COVID features how frontline doctors from various parts of the world struggled to get Ivermectin in the hands of patients who need it the most. Capuzzo…
-
FLCCC meta-review on the efficacy of Ivermectin as prophylaxis and treatment of COVID-19, now published in a journal
The metareview initially released by the Front Line COVID-19 Critical Care Alliance (FLCCC) last January 16, 2021, as an open-sourced document has passed peer review. The research may now be accessed from the American Journal of Therapeutics, May to July 2021 issue. The meta-analysis reviews 18 randomized controlled treatment trials (RCTs) of ivermectin for COVID-19…
-
Singapore study shows throat spray and hydroxychloroquine reduce risk of COVID-19
The following article was originally published by The Straits Times and republished by The Philippine Daily Inquirer last April 25, 2021. The article reports on the result of one study which shows that using a povidone-iodine throat spray or consuming hydroxychloroquine can reduce the risk of COVID-19 infection among healthy individuals living in areas with…
-
Bacolod Council to study Ivermectin as possible COVID treatment
In this article for Sunstar Bacolod published on April 15, 2021, writer Merlinda A. Pedrosa reports on a new resolution passed by the Bacolod City Council seeking for a “more intellectual, unbiased, scientific and no competitive financial interest debates and discussions for the inclusion of Ivermectin in the list of essential drugs against coronavirus disease.”…
-
Ivermectin not illegal, PNP and Malacañang agree to stop going after legit ivermectin sellers
In this April 14, 2021 article for The Philippine Daily Inquirer, Gabriel Pabico Lalu reports on the latest developments about ivermectin in the Philippines. The author says that House Deputy Speaker Bernadette Herrera-Dy has been able to meet with Executive Secretary Salvador Medialdea, Presidential Management Staff (PMS) chief Ferdinand Cui Jr., PNP chief General Debold…
-
PRINCIPLE Trial confirms Budesonide shortens recovery time in non-hospitalized COVID patients
The following article was published by University of Oxford on April 12, 2021. It reports on the findings of the Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) Trial. According to the study, early treatment with inhaled budesonide shortens recovery time by a median of three days in patients who…
-
No need for vaccines: Clinical trial shows alternative treatment can reduce COVID hospitalization by 90%
A study from Oxford University has confirmed the remarkable effectiveness of common asthma treatment Budesonide for treating COVID-19. The study was originally published as a pre-print in February[efn_note]See the pre-print article at https://www.medrxiv.org/content/10.1101/2021.02.04.21251134v1. A statement about this study was also released at https://www.ox.ac.uk/news/2021-02-09-common-asthma-treatment-reduces-need-hospitalisation-covid-19-patients-study.[/efn_note] The study finally passed peer-review and was published by The Lancet on…
